tbuckley/cabot-search huggingface dataset:
La gastrophotographie. Par Pierre Bernay.
Journal: JAMA (1933)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Annual Oration, on Abdominal Section for the Treatment of Intra-Peritoneal Injury
Authors: W. Mac Cormac
Journal: BMJ (1887)

PRESIDENT AND GENTLEMEN,-The reason, I 'apprehend, why modern surgery occupies so foremost a position is because of its success in curing disease and in dealing with maladies hitherto regarded as beyond the reach of art.Particular operative procedures are now distinguished by their boldness, completeness, and success.This greater success is based on sounder knowledge of the causes of disease and the principles of its treatment.
BOARD OF TRUSTEES.
Journal: JAMA (1899)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PERIPHERAL NEURITIS DUE TO SULFONAMIDE COMPOUNDS
Journal: JAMA (1941)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Endocrinology
Authors: Mark E. Molitch
Journal: JAMA (1990)

Diabetes mellitus continues to be a major public health problem that affects about 12 million Americans. Interesting new observations have been made regarding the development and progression of some complications of diabetes mellitus, especially nephropathy. About 25% of patients in dialysis units have diabetic nephropathy, which eventually affects about one third of those with insulin-dependent diabetes and 5% to 10% of those with non—insulin-dependent diabetes.<sup>1</sup>Certain factors may be important in predicting who may develop end-stage renal disease. Blacks, compared with whites, have an increased risk of developing end-stage renal disease that is 1.62 times greater for insulin-dependent diabetes and 3.93 times greater for non—insulin-dependent diabetes, possibly partly related to higher blood pressures in blacks.<sup>2</sup>A history of nephropathy in a diabetic sibling puts a person with insulin-dependent diabetes at considerably increased risk for developing nephropathy.<sup>3</sup>Having a parent with hypertension results in a threefold increased risk
Acute sporadic non-A, non-B, non-C, non-D, non-E hepatitis
Authors: F Rochling
Journal: Hepatology (1997)

Patients presenting with clinical and laboratory features consistent with a diagnosis of acute non-A, non-B hepatitis were evaluated for evidence of hepatitis C or hepatitis E infection and for evidence of severe or prolonged disease. Antibody to hepatitis C virus (anti-HCV) was detected in 75 of 108 (69%) patients, antibody to hepatitis E virus (anti-HEV) in three patients (3%), and neither antibody in 31 (29%) patients. One patient had both anti-HCV and anti-HEV. HCV RNA was not detected in sera from any of 20 patients with seronegative (non-ABCDE) hepatitis, but in all 10 patients with anti-HCV who were tested by polymerase chain reaction (PCR). Compared with patients with acute hepatitis C, those with non-ABCDE hepatitis had a lower incidence of parenteral risk factors (6% vs. 70%; P < .001), higher peak serum bilirubin levels (45% vs. 5% with peak levels > 15 mg/dL; P < .001), more prolonged jaundice (25% vs. 0% with peak bilirubin >5 weeks after onset; P < .01), more severe prothrombin time abnormalities (26% vs. 0% with >3 second prolongation; P < .001), more severe hypoalbuminemia (39% vs. 9% with albumin <3 g/dL; P < .01), and more frequent major clinical complications (13% vs. 0% with encephalopathy; P < .01; 10% vs. 0% with death or transplant; P = .024). Patients with acute non-ABCDE hepatitis were less likely to develop chronic hepatitis than those with acute hepatitis C (23% vs. 68%; P < .05). Thus, patients with acute non-ABCDE hepatitis are epidemiologically distinct from those with acute hepatitis C and have a significantly more severe acute illness.
Miami medical school leads the way in assisting Haitians while training family medicine residents
Authors: A. A. Skolnick
Journal: JAMA (1995)

ALTHOUGH HAITI may be a land of frightful want, some who are interested in the field of family medicine see the country as a land of promise. Among the first to recognize its potential is the University of Miami (Fla) School of Medicine, which has established a family practice residency rotation at Haiti's only teaching hospital, University Hospital in Port-au-Prince. Faculty members at the University of Miami School of Medicine are also helping Haiti's medical college set up its first family residency program, which they expect will be up and running in July 1996. According to Arthur Fournier, MD, professor of family medicine and community health and associate dean for community health affairs at Miami, the school's Haitian Outreach Programs came about because his daughter car-pools with the daughter of Bart Green, MD, chair of neurosurgery there. While Green had been interested in helping in Haiti for some time, the
Breast Cancer
Authors: Robert L. Egan
Journal: JAMA (1961)

<h3>To the Editor:—</h3> My attention has been called to an editorial on breast cancer in the July 1, 1961, issue ofThe Journal(<b>176</b>:1108). The table records doses measured for a typical set of 3 exposures on a breast of average size by a Victoreen cellophane chamber calibrated at the National Bureau of Standards. Except for small areas of field overlap, the dose to the skin is as listed for a single exposure. The radiographic equipment in use is a General Electric generator KX 8-9 and the HRTC-0.3-2 tube; the inherent filtration is 1-mm. Al equivalent at 100 kvp. The total dose at the center of the breast (assumed to be 6 cm. in thickness) for the above 3 exposures is approximately 3.3 r. If only the 2 views are considered, lateral and cephalocaudad referred to in the editorial, the midpoint of the breast receives 1.4 r. Allowance has
Forecasting Physician Workforce Requirements
Authors: Nathan W. Levin
Journal: JAMA (1995)

<h3>To the Editor.</h3> —In regard to Dr Weiner's<sup>1</sup>article on the physician staffing that will be required with health system reform, I would like to be assured that the comparison of staffing patterns in nephrology between HMOs and the US supply is a valid one. Because the prevalent end-stage renal disease population (in December 1991) was 721 patients per million population<sup>2</sup>and since a substantial fraction of nephrologists' clinical work is in the care of end-stage renal disease patients, it is important to know the prevalence of such patients in the 16 HMOs used for the comparison. In this group, the nephrology staffing was 0.6 to 0.9 nephrologist per 100 000 population compared with 1.1 per 100 000 in the United States. I hope that Weiner will provide this information. The adjusted end-stage renal disease prevalence rate is growing at an average rate of 9.3% per year, but
The rights of infants with Down's syndrome
Authors: G. F. Smith
Journal: JAMA (1984)

THERE are infants—some with Down's syndrome—who are born dying, in the sense that they are afflicted with an illness for which there is no definitive life-saving treatment, and they will inevitably die as neonates. The question is how they will live while dying. Conflicts may arise in these cases over the physician's obligation toward such patients. The physician clearly must provide comfort and relief of pain, but such arduous interventions as surgery and resuscitative therapy, which would merely prolong or aggravate the dying process, need not be undertaken. There are other infants who can clearly benefit from technically complex and costly interventions. Distinguishing the first group from the second is often difficult, and risk-benefit equations have to be weighed. In the case of infants with Down's syndrome, intelligent decisions can only be made by an attending physician knowledgeable about Down's syndrome and by parents who are well instructed about the
Myelography
Authors: R. Michael Scott
Journal: JAMA (1977)

<h3>To the Editor.—</h3> I was pleased to read the report of Batnitzky et al on iatrogenic intraspinal epidermoid tumors (237:148, 1977). I believe, however, that their conclusion that "myelography should be considered for every patient who has pain in the back or lower extremities and who has had previous lumbar punctures" is ill-advised and in fact not warranted by their own case material. If every patient who had back pain and a previous lumbar puncture underwent myelography, the vast majority of the studies would be negative. In fact, each of the patients in the article had back or radicular pain accompanied by abnormal findings on neurological examination, and, given the history in two of their three patients of previous CNS tumor, myelography would certainly have been performed even without the history of previous lumbar puncture. The authors have done us a service by reminding us of the relationship between lumbar
Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment
Authors: G. L. Knatterud
Journal: JAMA (1978)

The University Group Diabetes Program is a long-term prospective clinical trial designed to evaluate the effects of various hypoglycemic agents on vascular complications in patients with asymptomatic adult-onset diabetes. Mortality and blood glucose levels were determined as well as certain nonfatal events for patients assigned to diet alone or to either of two insulin treatment regimens. Lower levels of blood glucose with mean values close to normoglycemia were achieved in the treatment group in which the insulin dosage was adjusted to achieve normoglycemia compared with the levels achieved in patients treated with diet alone or with a fixed dose of insulin. In spite of differences in blood glucose levels among the treatment groups, there were only minor differences in the occurrence of fatal or nonfatal events. (<i>JAMA</i>240:37-42, 1978)
Post-Traumatic Stress Disorder
Authors: Arieh Shalev, Israel Liberzon, Charles Marmar
Journal: New England Journal of Medicine (2017)

PTSD is characterized by the persistence of intense reactions to reminders of a traumatic event, altered mood, a sense of imminent threat, disturbed sleep, and hypervigilance. Cognitive behavioral therapy and anxiolytic or antidepressant agents can ameliorate symptoms.
Neck Swellings
Authors: N. Roland, P. J. Bradley
Journal: BMJ (2014)

<h3>ABSTRACT</h3> Humans commonly have low level antibodies to poly(ethylene) glycol (PEG) due to environmental exposure. Lipid nanoparticle (LNP) mRNA vaccines for SARS-CoV-2 contain small amounts of PEG but it is not known whether PEG antibodies are enhanced by vaccination and what their impact is on particle–immune cell interactions in human blood. We studied plasma from 130 adults receiving either the BNT162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna) mRNA vaccines, or no SARS-CoV-2 vaccine for PEG-specific antibodies. Anti-PEG IgG was commonly detected prior to vaccination and was significantly boosted a mean of 13.1-fold (range 1.0 to 70.9) following mRNA-1273 vaccination and a mean of 1.78-fold (range 0.68 to 16.6) following BNT162b2 vaccination. Anti-PEG IgM increased 68.5-fold (range 0.9 to 377.1) and 2.64-fold (0.76 to 12.84) following mRNA-1273 and BNT162b2 vaccination, respectively. The rise in PEG-specific antibodies following mRNA-1273 vaccination was associated with a significant increase in the association of clinically relevant PEGylated LNPs with blood phagocytes <i>ex vivo</i>. PEG antibodies did not impact the SARS-CoV-2 specific neutralizing antibody response to vaccination. However, the elevated levels of vaccine-induced anti-PEG antibodies correlated with increased systemic reactogenicity following two doses of vaccination. We conclude that PEG-specific antibodies can be boosted by LNP mRNA-vaccination and that the rise in PEG-specific antibodies is associated with systemic reactogenicity and an increase of PEG particle–leukocyte association in human blood. The longer-term clinical impact of the increase in PEG-specific antibodies induced by lipid nanoparticle mRNA-vaccines should be monitored.
Suffering
Authors: Ariela Sarah Taub
Journal: JAMA (2015)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
APPLE News
Journal: Liver Cancer (2019)

AimsPrimary liver cancer is an extremely malignant disease, and 80% of patients are found in Asian countries.e APPLE Meetings have been initiated to provide a platform for regional and international experts to exchange information on the latest advancements in primary liver cancer treatment.e meetings are aimed at bridging gaps in the basic science and clinical aspects of liver cancer among specialists, with the ultimate aim of disseminating the results of laboratory research and clinical trials in liver cancer among professionals. Histor ye APPLE Meetings take place annually and have been hosted on rotation by the Korean Liver Cancer Study Group, the Liver Cancer Study Group of Japan, and the Chinese Liver Cancer Study Group.e 1st meeting of the group took place in Incheon in 2010, the 2nd in Osaka in 2011, the 3rd in Shanghai in 2012, and the 4th in Busan in 2013.In 2014, APPLE changed its policy and decided to expand its congress venues from three countries to include all Asian countries, and the 5th APPLE Meeting was held in Taipei in 2014.
THE OCCURRENCE OF PEPTIC ULCERS IN THE JEJUNUM AFTER GASTROENTEROSTOMY.
Journal: JAMA (1904)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Atmospheric CO2 consequences of heavy dependence on coal.
Authors: R M Rotty
Journal: Environmental Health Perspectives (1979)

Accurate and regular measurements of the concentration of CO2 in the atmosphere during the past 20 years show an accelerating increase. Although clearing of tropical forests has released large amounts of carbon to the atmosphere, evidence is strong that a major contributor is the combustion of fossil fuels. Future energy demands of the world will require extensive further exploitation of fossil fuels, and projections show that without major development of nonfossil fuel alternatives, the atmospheric concentration will double within the next 75 years. Four issues require serious attention. The developing countries will require vastly increased amounts of energy. Major efforts to develop suitable (inexpensive) nonfossil energy sources to meet at least a portion of this demand are required. The distribution of carbon released from fossil fuels and from other anthropogenic sources among the reservoirs of the carbon cycle must be better defined. Uncertainties regarding the effect of the increased concentration of CO2 in the atmosphere on global climate must be reduced. Possible political and social responses to a substantial climate change must be studied in order to more fully understand all of the implication of increased atmospheric CO2.
Introduction
Authors: John F. Rosen, Raymond F. Novak, Michael J. Galvin
Journal: Environmental Health Perspectives (1990)

The ultimate thrust that serves as the basis for bio- logical research is the need to understand the mechanism(s) that underline biological events.For example, over the years many theories have been advanced to explain the mechanism(s) of ischemia-induced cardiac injury.Subsequently, based on the results of numerous studies that supported or disproved mechanistic theories for ischemic injury, new pharmacological agents have been developed for meliorating the ischemic injury by blocking one or more of the mechanisms, e.g., calcium influx leading to injury.Similarly, the mecha- nism(s) by which environmental agents cause adverse health effects are of great interest.In general, many diseases affect primarily a single organ system, whereas environmental agents adversely affect a number of organ systems simultaneously.For example, certain pesticides have been shown to affect the cen- tral and peripheral nervous, reproductive, and digestive systems.Understanding the mechanism(s) of environmental agent-mediated toxicity is complicated further by the fact that some chemicals are intrinsi- cally toxic whereas others require metabolic conver- sion to toxic products in the body.Through our understanding of the processes by which environmen- tal agents affect human health, an agressive and effec- tive program for understanding, ameliorating, and